hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions.

Wen JiangCai ZhangZhigang TianJian Zhang

Published in: Journal of cancer research and clinical oncology (2018)

These results provided evidence that IL-15 gene-modification could augment NK cell-mediated anti-human leukemia function, which would improve primary NK cell-based immunotherapy for leukemia in future.

Keyphrases

endothelial cells
nk cells
acute myeloid leukemia
bone marrow
induced pluripotent stem cells
pluripotent stem cells
natural killer cells
genome wide
current status